苯甲酰胺
化学
细胞毒性
体内
体外
胶质瘤
下调和上调
IC50型
立体化学
药理学
癌变
铅化合物
细胞凋亡
流出
结构-活动关系
生物化学
癌症研究
基因
生物
生物技术
作者
Menghan Zhang,Yushi Ding,Mengkang Gao,Xiaolin Lü,Jun Tan,Fei Yu,Congying Gu,Lujun Gu,Xiameng Ren,Chenyan Hao,Liqin Ming,Kang Xu,Wenhao Mao,Yuqing Jin,Min Zhang,Linjun You,Zhanbo Wang,Yuanyuan Sun,Jingwei Jiang,Yong Yang
标识
DOI:10.1021/acs.jmedchem.3c02241
摘要
Targeting tumor stemness is an innovative approach to cancer treatment. Zinc Finger Protein 207 (ZNF207) is a promising target for weakening the stemness of glioma cells. Here, a series of novel N-(anthracen-9-ylmethyl) benzamide derivatives against ZNF207 were rationally designed and synthesized. The inhibitory activity was evaluated, and their structure-activity relationships were summarized. Among them, C16 exhibited the most potent inhibitory activity, as evidenced by its IC50 values ranging from 0.5-2.5 μM for inhibiting sphere formation and 0.5-15 μM for cytotoxicity. Furthermore, we found that C16 could hinder tumorigenesis and migration and promote apoptosis in vitro. These effects were attributed to the downregulation of stem-related genes. The in vivo evaluation demonstrated that C16 exhibited efficient permeability across the blood-brain barrier and potent efficacy in both subcutaneous and orthotopic glioma tumor models. Hence, C16 may serve as a potential lead compound targeting ZNF207 and has promising therapeutic potential for glioma.
科研通智能强力驱动
Strongly Powered by AbleSci AI